Log In
BCIQ
Print this Print this
 

E-58425

  Manage Alerts
Collapse Summary General Information
Company Esteve S.A.
DescriptionOral co-crystal formulation of tramadol and celecoxib
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat moderate to severe acute pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,000.0M

0

$1,000.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/12/2015

$1,000.0M

0

$1,000.0M

Get a free BioCentury trial today